GLP-1 Weight Loss Medications in Texas
Navigate GLP-1 access in Texas: telehealth rules, insurance without Medicaid expansion, and providers across the state.
Telehealth Prescribing
AllowedRestrictions
Texas enacted telehealth legislation (SB 1107, 2017) that requires providers to use audio-video technology. Texas Medical Board rules previously required an in-person visit before prescribing certain medications via telehealth, but this was relaxed for non-controlled substances. Providers must be licensed in Texas. Texas does NOT participate in the Interstate Medical Licensure Compact.
Prescribing Rules
GLP-1 receptor agonists are non-controlled and can be prescribed via telehealth in Texas. The initial in-person requirement that previously complicated Texas telehealth primarily applies to controlled substances. For GLP-1s, a video consultation establishing the provider-patient relationship is sufficient. Texas requires NPs to have a prescriptive authority agreement with a supervising physician.
Insurance Coverage
Medicaid Coverage
Prior Authorization
Major Insurers
Texas has NOT expanded Medicaid, leaving approximately 1.4 million adults in the coverage gap — the largest uninsured population in the nation. Texas Medicaid covers GLP-1s for diabetes for traditional eligible groups. Commercial coverage varies widely. Large employer plans in Houston, Dallas, Austin, and San Antonio often cover GLP-1s.
Cost Breakdown
Brand Name
$900-$1400
per month, without insurance
Compounded
Available$130-$400
per month
Top Providers in Texas
Ro
TelehealthLargest telehealth presence in Texas with compounded semaglutide; serves all 254 counties.
UTHealth Houston - Weight Management Center
BothAcademic obesity medicine program at the Texas Medical Center in Houston.
Baylor Scott & White Weight Loss Surgery & Medical Weight Management
BothLargest not-for-profit health system in Texas with GLP-1 programs across the DFW metro and beyond.
Texas Telehealth: Navigating the Rules
Texas telehealth regulations have been a source of confusion. SB 1107 (2017) established that providers must use audio-video technology, and the Texas Medical Board historically required initial in-person encounters for prescribing. However, this requirement primarily targets controlled substances. GLP-1 receptor agonists are not classified as controlled substances, so they can be prescribed via telehealth video consultation without a prior in-person visit. Texas not participating in the Interstate Medical Licensure Compact means providers must hold a Texas medical license specifically.
The Medicaid Gap: Texas Uninsured Challenge
Texas has the largest uninsured population in the United States, with approximately 5 million uninsured residents. The state has not expanded Medicaid, creating a coverage gap for adults earning between 14% and 138% of the federal poverty level. This disproportionately affects GLP-1 access — many Texans who would benefit from weight loss medications cannot afford brand-name pricing. Compounded semaglutide, patient assistance programs, and cash-pay clinics fill this gap partially.
Major Metro Provider Landscape
Texas has four of the 15 largest metro areas in the country, each with distinct healthcare ecosystems. Houston's Texas Medical Center is the largest medical complex in the world. Dallas-Fort Worth has Baylor Scott & White and UT Southwestern. Austin has growing healthcare infrastructure. San Antonio has the UT Health San Antonio system.
- Houston: Texas Medical Center, Memorial Hermann, Houston Methodist — extensive GLP-1 options
- Dallas-Fort Worth: Baylor Scott & White, UT Southwestern, Texas Health Resources
- Austin: Dell Medical School, Ascension Seton, growing telehealth-forward market
- San Antonio: UT Health SA, Methodist Healthcare, military-connected facilities
- Rural Texas: 254 counties, many without specialists — telehealth is essential
Compounding in Texas
Texas has a large and active compounding pharmacy industry. The Texas State Board of Pharmacy regulates both 503A and 503B compounding operations. Several Texas-based 503B outsourcing facilities produce compounded semaglutide for nationwide distribution. In-state access to compounded GLP-1s is excellent, with options in all major metros and shipping to rural areas. Cash-pay pricing for compounded semaglutide is among the most competitive in the nation due to market density.
Frequently Asked Questions
No. The initial in-person visit requirement in Texas applies primarily to controlled substances. GLP-1 medications are non-controlled and can be prescribed via telehealth video consultation.
Texas has not expanded Medicaid. Traditional Medicaid covers GLP-1s for diabetes for eligible groups (children, pregnant women, elderly, disabled). Most working adults do not qualify for Texas Medicaid.
Compounded semaglutide ($130-$400/month) through telehealth platforms offers the best value. Texas has competitive compounding pricing due to market size. Manufacturer savings cards and patient assistance programs are additional options.
Yes, but Texas NPs must have a prescriptive authority agreement with a supervising physician. They can prescribe GLP-1s through both in-person and telehealth encounters under this arrangement.
In-person specialists are rare in rural Texas. Telehealth platforms serve all 254 Texas counties. Baylor Scott & White and other systems also offer telehealth weight management consultations to rural patients.
Explore More
Related tools, medications, and guides